Slide Insurance Authorizes New $125 Million Share Repurchase Program After Completing Prior Buyback
SLDE sits 37% above its 52-week low of $12.53 on elevated volume (2.3× avg).
Summary
Slide Insurance Holdings, Inc. announced a new $125 million share repurchase program, immediately following the completion of its prior $120 million buyback.
Key Events · Financing and Capital Events · SLDE
-
New $125 Million Share Repurchase Program Authorized
The Board of Directors has authorized a new common stock repurchase program for an aggregate of up to $125 million, effective immediately and with no expiration date. Shares may be repurchased through various methods, including open market transactions and Rule 10b5-1 plans.
-
Prior $120 Million Program Completed
The company announced the completion of its initial $120 million common stock repurchase program, under which it repurchased 7,109,417 common shares at a weighted average price of $16.88 per share.
-
Management Expresses Confidence
CEO Bruce Lucas stated the new program reflects confidence in the company's long-term growth strategy, underwriting capabilities, and robust capital position, believing that repurchasing common stock below fair value is accretive to shareholders.
Analysis · SLDE · Finance
Slide Insurance Holdings, Inc. has authorized a new $125 million common stock repurchase program, signaling management's confidence in the company's valuation and future prospects. This follows the successful completion of a previous $120 million program, under which the company repurchased over 7.1 million shares. The continuous commitment to share buybacks, representing a significant portion of the company's market capitalization, suggests a strategic effort to enhance shareholder value and indicates that management views the stock as undervalued. Investors should monitor the execution of this program for its impact on share count and earnings per share.
At the time of this filing, SLDE was trading at $17.18 on NASDAQ in the Finance sector, with a market capitalization of approximately $2.1B. The 52-week trading range was $12.53 to $25.90. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.